Vogt Koyanagi Harada Disease
Date
2019
Type:
Book chapter
item.page.extent
item.page.accessRights
Authors
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
Vogt-Koyanagi-Harada (VKH) disease is an inflammatory and autoimmune
condition characterized by intraocular inflammation, serous retinal detachments,
and extraocular manifestations at the level of the auditory, integumentary, and
central nervous systems (CNS).
No epidemiological studies have been carried out on this condition. However, it
has been related to certain geographical areas, such as Latin America and Asia, with
a significant contribution of native origin. In this regard, its frequency has been
reported up to 22.4% of uveitis causes in referral centers around the world .
Recently, significant advances have been reported regarding treatment options
and novel approaches to evaluate and categorize this group of patients, in order
to personalize follow-up and management in each subject and thus achieve better
functional and anatomic outcomes
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Urzua, C., (2019). Vogt Koyanagi Harada Disease. Advances in the Diagnosis and Management of Uveitis. IntechOpen. https://doi.org/10.5772/intechopen.85261
Keywords
Vogt-Koyanagi-Harada disease, VKH, Vitiligo, Treatment response, Biomarkers